• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤倍增时间与乳腺癌筛查项目中的长度偏倚。

Tumour doubling times and the length bias in breast cancer screening programmes.

机构信息

Cardiff School of Mathematics, Cardiff University, Cardiff, Wales, UK.

出版信息

Health Care Manag Sci. 2011 Jun;14(2):203-11. doi: 10.1007/s10729-011-9156-9. Epub 2011 Mar 29.

DOI:10.1007/s10729-011-9156-9
PMID:21533752
Abstract

Screening for early detection of breast cancer is considered to be an important element of preventive medicine. In this paper, we use numerical simulations to examine the length bias in regular interval screening programmes, by computing the doubling times of breast cancer tumours detected through regular mammographies compared to self-detection. Our analysis shows that doubling times of tumours detected by a regular screening programme are longer than doubling times in the original whole population and considerably longer than those self-detected. Hence regular interval mammographies may be missing a high proportion of fast growing tumours and therefore the benefits of current screening programmes may need to be re-evaluated. We examine the likely size of the length bias for the present UK breast cancer screening programme and perform a sensitivity analysis by varying the screen detection probabilities to reflect future advances in mammographic detection.

摘要

筛查早期乳腺癌被认为是预防医学的重要组成部分。在本文中,我们通过数值模拟来研究定期间隔筛查计划中的长度偏差,通过计算定期乳房 X 光检查检测到的乳腺癌肿瘤与自我检测相比的倍增时间。我们的分析表明,定期筛查计划检测到的肿瘤倍增时间长于原始总体人群中的倍增时间,并且比自我检测到的倍增时间长得多。因此,定期间隔乳房 X 光检查可能会错过很大一部分快速生长的肿瘤,因此需要重新评估当前筛查计划的益处。我们检查了目前英国乳腺癌筛查计划中长度偏差的可能大小,并通过改变屏幕检测概率来进行敏感性分析,以反映乳房 X 光检测的未来进展。

相似文献

1
Tumour doubling times and the length bias in breast cancer screening programmes.肿瘤倍增时间与乳腺癌筛查项目中的长度偏倚。
Health Care Manag Sci. 2011 Jun;14(2):203-11. doi: 10.1007/s10729-011-9156-9. Epub 2011 Mar 29.
2
Radiological audit of interval breast cancers: Estimation of tumour growth rates.间期乳腺癌的放射学审核:肿瘤生长速度的评估。
Breast. 2020 Jun;51:114-119. doi: 10.1016/j.breast.2020.03.006. Epub 2020 Apr 1.
3
Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.马来西亚(一个中等收入亚洲国家)一项乳腺钼靶筛查补贴项目的实施情况。
BMC Public Health. 2017 Jan 28;17(1):127. doi: 10.1186/s12889-017-4015-3.
4
A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.一项模拟模型研究,探讨肿瘤体积倍增时间和乳腺钼靶肿瘤可探测性对 40-49 岁女性筛查结果的影响。
J Natl Cancer Inst. 2010 Aug 18;102(16):1263-71. doi: 10.1093/jnci/djq271. Epub 2010 Jul 27.
5
Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population.来自50至74岁筛查人群的浸润性导管癌的生长速率。
J Med Screen. 2018 Mar;25(1):40-46. doi: 10.1177/0969141316687791. Epub 2017 Jan 13.
6
Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study.基于人群的有组织计划和乳腺癌筛查中社会经济不平等的变化:1992-2012 年全国准实验研究。
Prev Med. 2018 Nov;116:19-26. doi: 10.1016/j.ypmed.2018.08.012. Epub 2018 Aug 24.
7
Mammographic screening for breast cancer: 2010.2010年乳腺癌的乳腺X线筛查。
Mt Sinai J Med. 2010 Jul-Aug;77(4):398-404. doi: 10.1002/msj.20194.
8
[Breast self-examination also valuable in women participating in a screening programme].乳房自我检查对参加筛查项目的女性也有价值。
Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2341-5.
9
Evolution of inequalities in breast and cervical cancer screening in Barcelona: population surveys 1992, 2001, and 2006.巴塞罗那地区乳腺癌和宫颈癌筛查中不平等现象的演变:1992 年、2001 年和 2006 年的人群调查。
J Womens Health (Larchmt). 2011 Nov;20(11):1721-7. doi: 10.1089/jwh.2010.2478. Epub 2011 Jul 6.
10
Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.与筛查检出的乳腺癌相比,间隔期乳腺癌的发病情况、特征和结局。
JAMA Netw Open. 2020 Sep 1;3(9):e2018179. doi: 10.1001/jamanetworkopen.2020.18179.

引用本文的文献

1
Estimating the Benefits of Oral Cancer Screening: Challenges and Opportunities.评估口腔癌筛查的益处:挑战与机遇
Cancers (Basel). 2024 Dec 8;16(23):4110. doi: 10.3390/cancers16234110.
2
A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer.一种预测雌激素受体/孕激素受体/人表皮生长因子受体2/ Ki-67亚型乳腺癌患者继发性远处转移诊断期的数学模型。
Cancers (Basel). 2020 Aug 19;12(9):2344. doi: 10.3390/cancers12092344.
3
Operational research techniques applied throughout cancer care services: a review.

本文引用的文献

1
Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort.基于人群的服务性筛查(乳腺 X 线摄影术)对 40 至 49 岁女性的有效性:对瑞典年轻女性乳腺 X 线筛查(SCRY)队列的评估。
Cancer. 2011 Feb 15;117(4):714-22. doi: 10.1002/cncr.25650. Epub 2010 Sep 29.
2
Screening for breast cancer--balancing the debate.乳腺癌筛查——权衡争议
BMJ. 2010 Jun 24;340:c3106. doi: 10.1136/bmj.c3106.
3
Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia.
运筹学技术在癌症护理服务中的应用综述
Health Syst (Basingstoke). 2018 Jan 17;8(1):52-73. doi: 10.1080/20476965.2017.1414741. eCollection 2019.
人群筛查及筛查强度与降低乳腺癌死亡率相关:澳大利亚乳腺钼靶筛查效果的证据
Breast Cancer Res Treat. 2008 Apr;108(3):409-16. doi: 10.1007/s10549-007-9609-5. Epub 2007 May 22.
4
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.用于分析美国乳腺癌发病率和死亡率趋势的CISNET乳腺癌模型的比较综述。
J Natl Cancer Inst Monogr. 2006(36):96-105. doi: 10.1093/jncimonographs/lgj013.
5
Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem.模拟1975年至2000年间辅助治疗和乳腺钼靶筛查对美国乳腺癌死亡率的影响:问题介绍
J Natl Cancer Inst Monogr. 2006(36):2-6. doi: 10.1093/jncimonographs/lgj002.
6
A 13-year follow-up of patients with breast cancer presenting to a District General Hospital breast unit in southeast England.对英国东南部一家地区综合医院乳腺科收治的乳腺癌患者进行的13年随访。
Breast. 2006 Apr;15(2):173-80. doi: 10.1016/j.breast.2005.06.002. Epub 2005 Aug 2.
7
Evaluation of service screening mammography in practice: the impact on breast cancer mortality.
Ann Oncol. 2005;16 Suppl 2:ii153-62. doi: 10.1093/annonc/mdi718.
8
International comparison of performance measures for screening mammography: can it be done?乳腺钼靶筛查性能指标的国际比较:可行吗?
J Med Screen. 2004;11(4):187-93. doi: 10.1258/0969141042467430.
9
Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.乳腺癌筛查模型方法的多样性:癌症干预与监测网络(CISNET)乳腺癌小组对模型假设的综述
Stat Methods Med Res. 2004 Dec;13(6):525-38. doi: 10.1191/0962280204sm381ra.
10
Cochrane review on screening for breast cancer with mammography.考克兰关于乳腺钼靶筛查乳腺癌的综述。
Lancet. 2001 Oct 20;358(9290):1340-2. doi: 10.1016/S0140-6736(01)06449-2.